Rohan Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.46 Cr
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.04 Cr
- Satisfied Charges ₹ 3.40 Cr
- Revenue Growth -7.52%
- Profit Growth -76.17%
- Ebitda -73.17%
- Net Worth
- Total Assets -15.65%
About Rohan Pharma
Rohan Pharma Private Limited (RPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 December 1996 and has a history of 28 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.46 Cr.
The company currently has active open charges totaling ₹10.04 Cr. The company has closed loans amounting to ₹3.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gireesh Sardana, Anita Sardana, Rohan Sardana, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231DL1996PTC083978
- Company No.
083978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rohan Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohan Sardana  | Whole-Time Director | 21-Dec-1996 | Current |
| Gireesh Sardana | Whole-Time Director | 20-Dec-1996 | Current |
| Anita Sardana | Director | 20-Dec-1996 | Current |
| Ankita Sardana | Director | 27-Jul-2021 | Current |
Financial Performance of Rohan Pharma.
Rohan Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.52% decrease. The company also saw a substantial fall in profitability, with a 76.17% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rohan Pharma?
In 2022, Rohan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foil Nest Private LimitedAnkita Sardana is a mutual person
Charges (Loans)
₹10.04 Cr
₹3.40 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 10.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jul 2020 | Axis Bank Limited | ₹5.40 M | Open |
| 10 Dec 2019 | Axis Bank Limited | ₹9.50 Cr | Open |
| 30 Mar 2023 | Others | ₹7.50 M | Satisfied |
| 25 Apr 2019 | Others | ₹2.25 Cr | Satisfied |
| 09 Mar 2007 | State Bank Of Travencore | ₹4.00 M | Satisfied |
How Many Employees Work at Rohan Pharma?
Unlock and access historical data on people associated with Rohan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rohan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rohan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.